Clinic
Planned Parenthood California Central Coast
Planned Parenthood California Central Coast was paid $7.00M by Medicaid between Jan 2018 and Dec 2024, across 62 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 12% of everything it billed.
33Billing provider infoPLANNED PARENTHOOD CALIFORNIA CENTRAL COAST
VENTURA, CA 93003
VENTURA, CA 93003
33aNPI1184641664assigned 07/17/2006
33bProvider typeCommunity Health Clinic/Center
28Total paid$7.00M
24GClaims129,679
24DCodes billed62
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Community Health Clinic/Center providers in California
Rank by total paid#49 of 288
Median peer was paid$2.15M
This provider vs. median3.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 31,329 | $1.69M | |
| 2019 | 19,190 | $1.13M | |
| 2020 | 11,600 | $585K | |
| 2021 | 15,536 | $825K | |
| 2022 | 22,353 | $1.26M | |
| 2023 | 18,406 | $983K | |
| 2024incomplete | 11,265 | $518K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 12% | 9,228 | 8,898 | $805K |
| S4993 | Contraceptive pills for birth control | 10% | 6,691 | 6,538 | $732K |
| J3490 | Unclassified drugs | 10% | 15,590 | 14,006 | $729K |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 9.9% | 1,121 | 1,103 | $695K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 9.4% | 613 | 565 | $659K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 6.2% | 6,797 | 6,522 | $435K |
| 87806 | 5.9% | 14,950 | 13,425 | $411K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.7% | 2,212 | 2,174 | $326K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 4.5% | 7,196 | 7,034 | $314K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 3.9% | 2,452 | 2,377 | $273K |
| 59840 | 2.9% | 1,001 | 636 | $205K | |
| 99201 | 2.4% | 1,829 | 1,821 | $170K |
50 more codes
| 58300 | 1.8% | 1,090 | $124K | |
| A4267 | Contraceptive supply, condom, male, each | 1.7% | 10,643 | $116K |
| 99203 | Doctor's office visit, new patient (routine) | 1.6% | 659 | $113K |
| 11981 | 1.5% | 483 | $106K | |
| 0520 | 1.4% | 670 | $95K | |
| S0190 | Mifepristone, oral, 200 mg | <1% | 1,005 | $69K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 831 | $66K |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | <1% | 98 | $63K |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 3,110 | $40K |
| 81025 | <1% | 12,328 | $38K | |
| 11976 | <1% | 560 | $35K | |
| J7300 | Intrauterine copper contraceptive (paragard) | <1% | 39 | $34K |
| 86780 | <1% | 2,889 | $33K | |
| A4649 | Surgical supply; miscellaneous | <1% | 2,268 | $30K |
| 86703 | <1% | 2,610 | $28K | |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | <1% | 24 | $23K |
| S5000 | Prescription drug, generic | <1% | 2,174 | $23K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 732 | $21K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 695 | $20K |
| 99152 | <1% | 368 | $20K | |
| 86803 | <1% | 1,150 | $17K | |
| J7297 | Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg | <1% | 14 | $14K |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 1,669 | $10K |
| 83986 | <1% | 3,101 | $10K | |
| J7304 | Contraceptive supply, hormone containing patch, each | <1% | 12 | $10K |
| 87808 | <1% | 864 | $9K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 254 | $9K |
| 58301 | <1% | 258 | $9K | |
| 99000 | <1% | 1,977 | $8K | |
| 87210 | <1% | 2,013 | $7K | |
| J7295 | Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each | <1% | 12 | $7K |
| 99402 | <1% | 176 | $6K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 43 | $5K |
| 64435 | <1% | 155 | $5K | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 1,008 | $4K |
| 85018 | <1% | 1,059 | $2K | |
| 11982 | <1% | 32 | $2K | |
| 90674 | <1% | 59 | $2K | |
| 81002 | <1% | 780 | $2K | |
| S0191 | Misoprostol, oral, 200 mcg | <1% | 1,222 | $1K |
| 0300 | <1% | 140 | $921.79 | |
| 88142 | <1% | 69 | $823.46 | |
| 86901 | <1% | 316 | $733.09 | |
| 86592 | <1% | 129 | $524.81 | |
| 99401 | <1% | 50 | $447.50 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 12 | $269.51 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 39 | $216.27 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 34 | $155.15 |
| 86701 | <1% | 14 | $101.42 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 62 | $21.45 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTOSH, JENNA (PRESIDENT/CEO)
| Provider | Location | Paid |
|---|---|---|
| Planned Parenthood California Central Coast | Santa Maria, CA | $9.28M |
| Planned Parenthood California Central Coast | Santa Barbara, CA | $6.15M |
| Planned Parenthood California Central Coast | San Luis Obispo, CA | $4.68M |
| Planned Parenthood California Central Coast | San Jose, CA | $3.88M |
| Planned Parenthood California Central Coast | Thousand Oaks, CA | $3.63M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.